TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010Vol.36 No.14
TCL Archive FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011 April 16, 2010Vol.36 No.14
TCL Archive Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients. April 09, 2010Vol.36 No.13
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 09, 2010Vol.36 No.13
TCL Archive Report Urges Changes To Cut Activation Times For NCI Phase III Trials. April 09, 2010Vol.36 No.13
